#China's vaccine, the CanSino candidate, is one of a handful of vaccines that have shown some promise in early human testing. The phase 1 and 2 trial results from a vaccine developed by researchers at the University of Oxford and British-Swedish company AstraZeneca were also released on Monday. How will this vaccine be rolled out in practice?

Guests:
Eric Ding
Senior Fellow, Federation of American Scientists

Dr Wu Zhiwei
Medical School of Nanjing University

Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv

Follow us on:
Website: https://www.cgtn.com/
Facebook: https://www.facebook.com/ChinaGlobalTVNetwork/
Twitter: https://twitter.com/CGTNOfficial
Instagram: https://www.instagram.com/cgtn/?hl=zh-cn
Pinterest: https://www.pinterest.com/CGTNOfficial/
Weibo: http://weibo.com/cctvnewsbeijing
Douyin: http://v.douyin.com/aBbmNQ/